Effect of an inhaled glucocorticosteroid (budesonide) on post-antigen induced increases in airway responsiveness

W. M. Abrahams, S. Lanes, J. S. Stevenson, L. D. Yerger

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

We have examined the effects of an inhaled glucocorticosteroid, budesonide, on antigen-induced early and late bronchial responses and the development 24 h after challenge of increased airway responsiveness to carbachol in allergic sheep. Six allergic sheep were used for this study and, on occasions separated by at least three weeks, they were treated: with placebo (treatment 1); 16 h and 20 min prior to antigen challenge with budesonide (treatment 2); 16 h and 20 min prior to and 8 h after antigen challenge with budesonide (treatment 3); or 16 h and 1 h prior to and 8 h after antigen challenge with budesonide (treatment 4). Airway responsiveness to carbachol was determined prior to and 24 h after antigen challenge by measuring specific lung resistance (sRL) after administering increasing doses of carbachol aerosol (0.5, 1 and 2.5% w/v) and determining the concentration of carbachol needed to increase sRL 150% over baseline (PC150). Placebo treatment did not affect the early or late increases in sRL after airway challenge with Ascaris suum antigen; 24 h after challenge, airway responsiveness to carbachol increased ( p<0.05); at this time, PC150 was (x̄ ± SEM) 0.88 ± 0.15% as compared to 1.56 ± 0.26% before challenge. Both treatments 2 and 3 blunted the early response to antigen and blocked the late response, but treatment 2 did not modify the antigen-induced increase in airway responsiveness, whereas treatment 3 did. Treatment 4 blocked both antigen-induced responses and was effective in blunting the increased airway responsiveness. These results suggest that antigen-induced increases in airway responsiveness: a) occur 24 h after a challenge in allergic sheep with early and late responses; b) can be blunted by budesonide; and c) are not dependent on the late response.

Original languageEnglish
Pages (from-to)387-392
Number of pages6
JournalClinical Respiratory Physiology
Volume22
Issue number4
StatePublished - Jan 1 1986
Externally publishedYes

Fingerprint

Budesonide
Antigens
Carbachol
Sheep
Therapeutics
Placebos
Ascaris suum
Aerosols

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Effect of an inhaled glucocorticosteroid (budesonide) on post-antigen induced increases in airway responsiveness. / Abrahams, W. M.; Lanes, S.; Stevenson, J. S.; Yerger, L. D.

In: Clinical Respiratory Physiology, Vol. 22, No. 4, 01.01.1986, p. 387-392.

Research output: Contribution to journalArticle

Abrahams, W. M. ; Lanes, S. ; Stevenson, J. S. ; Yerger, L. D. / Effect of an inhaled glucocorticosteroid (budesonide) on post-antigen induced increases in airway responsiveness. In: Clinical Respiratory Physiology. 1986 ; Vol. 22, No. 4. pp. 387-392.
@article{7242a4af8d964b509935b9b8e0ba4659,
title = "Effect of an inhaled glucocorticosteroid (budesonide) on post-antigen induced increases in airway responsiveness",
abstract = "We have examined the effects of an inhaled glucocorticosteroid, budesonide, on antigen-induced early and late bronchial responses and the development 24 h after challenge of increased airway responsiveness to carbachol in allergic sheep. Six allergic sheep were used for this study and, on occasions separated by at least three weeks, they were treated: with placebo (treatment 1); 16 h and 20 min prior to antigen challenge with budesonide (treatment 2); 16 h and 20 min prior to and 8 h after antigen challenge with budesonide (treatment 3); or 16 h and 1 h prior to and 8 h after antigen challenge with budesonide (treatment 4). Airway responsiveness to carbachol was determined prior to and 24 h after antigen challenge by measuring specific lung resistance (sRL) after administering increasing doses of carbachol aerosol (0.5, 1 and 2.5{\%} w/v) and determining the concentration of carbachol needed to increase sRL 150{\%} over baseline (PC150). Placebo treatment did not affect the early or late increases in sRL after airway challenge with Ascaris suum antigen; 24 h after challenge, airway responsiveness to carbachol increased ( p<0.05); at this time, PC150 was (x̄ ± SEM) 0.88 ± 0.15{\%} as compared to 1.56 ± 0.26{\%} before challenge. Both treatments 2 and 3 blunted the early response to antigen and blocked the late response, but treatment 2 did not modify the antigen-induced increase in airway responsiveness, whereas treatment 3 did. Treatment 4 blocked both antigen-induced responses and was effective in blunting the increased airway responsiveness. These results suggest that antigen-induced increases in airway responsiveness: a) occur 24 h after a challenge in allergic sheep with early and late responses; b) can be blunted by budesonide; and c) are not dependent on the late response.",
author = "Abrahams, {W. M.} and S. Lanes and Stevenson, {J. S.} and Yerger, {L. D.}",
year = "1986",
month = "1",
day = "1",
language = "English",
volume = "22",
pages = "387--392",
journal = "Clinical Respiratory Physiology",
issn = "0272-7587",
publisher = "Pergamon Press Ltd.",
number = "4",

}

TY - JOUR

T1 - Effect of an inhaled glucocorticosteroid (budesonide) on post-antigen induced increases in airway responsiveness

AU - Abrahams, W. M.

AU - Lanes, S.

AU - Stevenson, J. S.

AU - Yerger, L. D.

PY - 1986/1/1

Y1 - 1986/1/1

N2 - We have examined the effects of an inhaled glucocorticosteroid, budesonide, on antigen-induced early and late bronchial responses and the development 24 h after challenge of increased airway responsiveness to carbachol in allergic sheep. Six allergic sheep were used for this study and, on occasions separated by at least three weeks, they were treated: with placebo (treatment 1); 16 h and 20 min prior to antigen challenge with budesonide (treatment 2); 16 h and 20 min prior to and 8 h after antigen challenge with budesonide (treatment 3); or 16 h and 1 h prior to and 8 h after antigen challenge with budesonide (treatment 4). Airway responsiveness to carbachol was determined prior to and 24 h after antigen challenge by measuring specific lung resistance (sRL) after administering increasing doses of carbachol aerosol (0.5, 1 and 2.5% w/v) and determining the concentration of carbachol needed to increase sRL 150% over baseline (PC150). Placebo treatment did not affect the early or late increases in sRL after airway challenge with Ascaris suum antigen; 24 h after challenge, airway responsiveness to carbachol increased ( p<0.05); at this time, PC150 was (x̄ ± SEM) 0.88 ± 0.15% as compared to 1.56 ± 0.26% before challenge. Both treatments 2 and 3 blunted the early response to antigen and blocked the late response, but treatment 2 did not modify the antigen-induced increase in airway responsiveness, whereas treatment 3 did. Treatment 4 blocked both antigen-induced responses and was effective in blunting the increased airway responsiveness. These results suggest that antigen-induced increases in airway responsiveness: a) occur 24 h after a challenge in allergic sheep with early and late responses; b) can be blunted by budesonide; and c) are not dependent on the late response.

AB - We have examined the effects of an inhaled glucocorticosteroid, budesonide, on antigen-induced early and late bronchial responses and the development 24 h after challenge of increased airway responsiveness to carbachol in allergic sheep. Six allergic sheep were used for this study and, on occasions separated by at least three weeks, they were treated: with placebo (treatment 1); 16 h and 20 min prior to antigen challenge with budesonide (treatment 2); 16 h and 20 min prior to and 8 h after antigen challenge with budesonide (treatment 3); or 16 h and 1 h prior to and 8 h after antigen challenge with budesonide (treatment 4). Airway responsiveness to carbachol was determined prior to and 24 h after antigen challenge by measuring specific lung resistance (sRL) after administering increasing doses of carbachol aerosol (0.5, 1 and 2.5% w/v) and determining the concentration of carbachol needed to increase sRL 150% over baseline (PC150). Placebo treatment did not affect the early or late increases in sRL after airway challenge with Ascaris suum antigen; 24 h after challenge, airway responsiveness to carbachol increased ( p<0.05); at this time, PC150 was (x̄ ± SEM) 0.88 ± 0.15% as compared to 1.56 ± 0.26% before challenge. Both treatments 2 and 3 blunted the early response to antigen and blocked the late response, but treatment 2 did not modify the antigen-induced increase in airway responsiveness, whereas treatment 3 did. Treatment 4 blocked both antigen-induced responses and was effective in blunting the increased airway responsiveness. These results suggest that antigen-induced increases in airway responsiveness: a) occur 24 h after a challenge in allergic sheep with early and late responses; b) can be blunted by budesonide; and c) are not dependent on the late response.

UR - http://www.scopus.com/inward/record.url?scp=0022525532&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022525532&partnerID=8YFLogxK

M3 - Article

VL - 22

SP - 387

EP - 392

JO - Clinical Respiratory Physiology

JF - Clinical Respiratory Physiology

SN - 0272-7587

IS - 4

ER -